Medication info
Cansata Tablet 16 mg (Candesaartan Cilexetil)

Cansata Tablet 16 mg (Candesaartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Kyung Dong Pharmaceutical Co., Ltd.
Appearance
Light pink tablet, convex on both sides with a line for splitting on one side
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201007652 · Notified 2010.12.22 · Insurance code 648102970

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: An initial and maintenance dose of candesartan cilexetil 8 ∼ 16 mg orally once daily is recommended. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled with this dose, other treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg, with careful monitoring, in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience is limited in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Ingredients

Manufacturer
Kyung Dong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular contractile function
  • reduced left ventricular ejection fraction
View approved original text

This medication is used to treat essential hypertension, which is high blood pressure of unknown cause. It is especially helpful for heart failure patients with impaired left ventricular contractile function that leads to decreased heart function. It is also effective for heart failure patients who need to take additional ACE inhibitors or who do not tolerate ACE inhibitors well. This helps control blood pressure and alleviate the heart's burden, thus improving symptoms. Therefore, it is widely used in the treatment of essential hypertension and heart failure.

How to take

Adult dose

Take this medicine at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: An initial and maintenance dose of candesartan cilexetil 8 ∼ 16 mg orally once daily is recommended. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is not controlled with this dose, other treatment should be considered. The maximum effect occurs within 4 weeks of starting treatment. 2) Elderly: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: Use an initial dose of 4 mg, with careful monitoring, in patients at high risk of hypotension, such as those with volume depletion. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience is limited in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). 5) Patients with hepatic impairment: The initial dose for patients with mild or moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. Double the dose at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild ∼ moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension 6) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger. 2. Heart failure 3) Children: Safety and efficacy have not been established in adolescents and children 18 years of age or younger.

Precautions

This medication can cause serious harm to the fetus during pregnancy, so it must be stopped immediately upon confirmation of pregnancy. Patients who are allergic to this drug or its ingredients, pregnant or nursing women, those with severe liver disease or cholestasis, patients with a history of angioedema, and those with certain genetic disorders should not take this medication. Elderly patients, those with weakened kidney function, patients with hyperkalemia, and those with heart valve diseases should take this medication with caution, and blood pressure, kidney function, and serum potassium levels should be monitored regularly during treatment. Side effects such as dizziness, back pain, respiratory infections may occur; in severe cases, hypotension, worsening kidney function, and blood abnormalities may arise. If unusual symptoms occur, a doctor should be consulted immediately. There may be interactions with other medications, so it is essential to inform the doctor or pharmacist, particularly when taken in combination with potassium-sparing diuretics or non-steroidal anti-inflammatory drugs. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers should also avoid taking it. If unavoidable, breastfeeding should be discontinued. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, so appropriate treatment must be sought at a medical institution immediately. This medication should be stored out of reach of children and should not be transferred to another container for safety. Caution is needed while driving or operating machinery as dizziness may occur.

Side effects

  • Dizziness
  • back pain
  • respiratory infections
  • weakness
  • fever
  • sensory disturbances
  • indigestion
  • gastritis
  • tachycardia
  • palpitations
Show 68 more
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • nosebleeds
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal function impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • increased γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • elevated myoglobin
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • increased tension
  • syncope
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • reduced libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • taste disturbances
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Light pink tablet, convex on both sides with a line for splitting on one side

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.